相关实验视频
Updated: May 23, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
249
对患者的方法:肥胖男性丸激素度低
Christopher A Muir1,2,3, Gary A Wittert4,5, David J Handelsman1,6
1Department of Andrology, Concord Repatriation General Hospital, Sydney, NSW, Australia.
The Journal of clinical endocrinology and metabolism
|March 7, 2025
概括
肥胖会导致丸激素降低,模仿过敏性腺体,但减肥往往会扭转这种情况. 对这些可逆性疾病来说,改变生活方式比激素治疗更有效.
科学领域:
- 内分泌学 在内分泌学.
- 男人的健康 男人的健康
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 病理性性腺缺陷症是由于不可逆转的HPT轴障碍导致的,需要终身的替代治疗.
- 肥胖经常导致轻度降低丸激素,通常是可逆的,被认为是非淋巴腺疾病综合征.
- 肥胖症中性激素结合环球蛋白 (SHBG) 的降低显著影响测量的水平.
研究的目的:
- 为了区分病理性阴性双胞胎症与与肥胖相关的丸激素降低.
- 评估减肥对肥胖男性丸激素水平及其相关症状的影响.
- 评估生活方式干预措施与丸激素治疗对肥胖的伪阴性腺体的疗效.
主要方法:
- 对血清丸激素,SHBG,LH和FSH水平与肥胖和并发症相关的分析.
- 与雄激素缺乏相关的症状的临床评估.
- 评估显著减肥后的结果和管理与肥胖相关的疾病.
主要成果:
- 与肥胖相关的丸激素降低通常是伪阴高性恋,由正常的LH/FSH证实.
- 临床上显著的体重减轻大大逆转降低丸激素和改善症状.
- 生活方式干预措施在与肥胖相关的丸激素降低方面比丸激素治疗更有效.
结论:
- 肥胖的伪性合性合性不同于病理性合性合性合性,并且是可逆的.
- 减肥和伴随疾病的管理是与肥胖相关的丸激素减少的主要治疗方法.
- 肥胖男性不必要的丸激素治疗可能会导致不良反应,因此不适合使用.
相关概念视频
Obesity
357
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
357
Disorders of the Male Reproductive System
285
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
285
Infertility in Males
226
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
226
Hypoglycemia and Glucagon
148
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
148
Testosterone: Functions and Regulation
510
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
510
Menopause
112
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
112

